BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 20510263)

  • 1. Advances in the understanding of the pathogenesis and epidemiology of herpes zoster.
    Gershon AA; Gershon MD; Breuer J; Levin MJ; Oaklander AL; Griffiths PD
    J Clin Virol; 2010 May; 48 Suppl 1(Suppl 1):S2-7. PubMed ID: 20510263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogenesis and current approaches to control of varicella-zoster virus infections.
    Gershon AA; Gershon MD
    Clin Microbiol Rev; 2013 Oct; 26(4):728-43. PubMed ID: 24092852
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Patil A; Goldust M; Wollina U
    Viruses; 2022 Jan; 14(2):. PubMed ID: 35215786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Latency of varicella zoster virus; a persistently perplexing state.
    Kinchington PR
    Front Biosci; 1999 Feb; 4():D200-11. PubMed ID: 9989948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of T cell responses during active varicella-zoster virus reactivation in human ganglia.
    Steain M; Sutherland JP; Rodriguez M; Cunningham AL; Slobedman B; Abendroth A
    J Virol; 2014 Mar; 88(5):2704-16. PubMed ID: 24352459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunization to reduce the frequency and severity of herpes zoster and its complications.
    Oxman MN
    Neurology; 1995 Dec; 45(12 Suppl 8):S41-6. PubMed ID: 8545018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breadth and Functionality of Varicella-Zoster Virus Glycoprotein-Specific Antibodies Identified after Zostavax Vaccination in Humans.
    Sullivan NL; Reuter-Monslow MA; Sei J; Durr E; Davis CW; Chang C; McCausland M; Wieland A; Krah D; Rouphael N; Mehta AK; Mulligan MJ; Pulendran B; Ahmed R; Vora KA
    J Virol; 2018 Jul; 92(14):. PubMed ID: 29743372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Varicella and herpes zoster. Part 1: virology, epidemiology, clinical picture, laboratory diagnostics].
    Wittek M; Doerr HW; Allwinn R
    Med Klin (Munich); 2010 May; 105(5):334-8. PubMed ID: 20503007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of the varicella vaccination program on herpes zoster epidemiology in the United States: a review.
    Reynolds MA; Chaves SS; Harpaz R; Lopez AS; Seward JF
    J Infect Dis; 2008 Mar; 197 Suppl 2():S224-7. PubMed ID: 18419401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current In Vitro Models to Study Varicella Zoster Virus Latency and Reactivation.
    Baird NL; Zhu S; Pearce CM; Viejo-Borbolla A
    Viruses; 2019 Jan; 11(2):. PubMed ID: 30691086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utility of ultra-deep sequencing for detection of varicella-zoster virus antiviral resistance mutations.
    Mercier-Darty M; Boutolleau D; Lepeule R; Rodriguez C; Burrel S
    Antiviral Res; 2018 Mar; 151():20-23. PubMed ID: 29337163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Reactivation of herpes zoster infection by varicella-zoster virus].
    Cvjetković D; Jovanović J; Hrnjaković-Cvjetković I; Brkić S; Bogdanović M
    Med Pregl; 1999; 52(3-5):125-8. PubMed ID: 10518396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent Issues in Varicella-Zoster Virus Latency.
    Kennedy PGE; Mogensen TH; Cohrs RJ
    Viruses; 2021 Oct; 13(10):. PubMed ID: 34696448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrent herpes zoster in the Shingles Prevention Study: Are second episodes caused by the same varicella-zoster virus strain?
    Harbecke R; Jensen NJ; Depledge DP; Johnson GR; Ashbaugh ME; Schmid DS; Breuer J; Levin MJ; Oxman MN
    Vaccine; 2020 Jan; 38(2):150-157. PubMed ID: 31679866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Routine Varicella Immunization on the Epidemiology and Immunogenicity of Varicella and Shingles.
    Otani N; Shima M; Yamamoto T; Okuno T
    Viruses; 2022 Mar; 14(3):. PubMed ID: 35336994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence and clinical characteristics of herpes zoster among children in the varicella vaccine era, 2005-2009.
    Weinmann S; Chun C; Schmid DS; Roberts M; Vandermeer M; Riedlinger K; Bialek SR; Marin M
    J Infect Dis; 2013 Dec; 208(11):1859-68. PubMed ID: 23922376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune evasion as a pathogenic mechanism of varicella zoster virus.
    Abendroth A; Arvin AM
    Semin Immunol; 2001 Feb; 13(1):27-39. PubMed ID: 11289797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrating between-host transmission and within-host immunity to analyze the impact of varicella vaccination on zoster.
    Ogunjimi B; Willem L; Beutels P; Hens N
    Elife; 2015 Jul; 4():. PubMed ID: 26259874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The neurotropic herpes viruses: herpes simplex and varicella-zoster.
    Steiner I; Kennedy PG; Pachner AR
    Lancet Neurol; 2007 Nov; 6(11):1015-28. PubMed ID: 17945155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Varicella-zoster virus neurotropism in SCID mouse-human dorsal root ganglia xenografts.
    Zerboni L; Reichelt M; Arvin A
    Curr Top Microbiol Immunol; 2010; 342():255-76. PubMed ID: 20225014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.